CEN case reports · 2020
Melanotan II: a possible cause of renal infarction: review of the literature and case report.
Клинический случайСтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Peters Björn, Hadimeri Henrik, Wahlberg Rebecka, Afghahi Henri
Аннотация
Renal infarction is an uncommon condition resulting from an acute disruption of renal blood flow and it is potentially life-threatening disease. The cause and outcome of renal infarction is not well established and is frequently misdiagnosed or diagnosed late. Melanotan II is a non-selective melanocortin-receptor agonist and its effect on humans is an increasing of skin pigmentation, producing of spontaneous penile erection and sexual stimulation. Melanotan II inducing rhabdomyolysis and renal failure have been described previously. We present a review of Melanotan II and the possible effects of this drug on the kidneys by including a case of a renal infarction most likely attributed to Melanotan II. In the mechanism of renal injury with Melanotan II, thrombotic pharmacological influence and possible direct toxic effect on renal parenchyma must be considered.
Предметные рубрики MeSH
Acute Kidney InjuryAngiotensin-Converting Enzyme InhibitorsDiagnostic ErrorsHeparin, Low-Molecular-WeightHumansHypertensionInfarctionKidneyMaleMiddle AgedPenile ErectionPeptides, CyclicReceptors, MelanocortinRhabdomyolysisSexual ArousalSkin PigmentationTomography, X-Ray ComputedTreatment Outcomealpha-MSH